Q1 pockets of improvement, but still not a clear path

Research evidence excerpt

Q1 pockets of improvement, but still not a clear path

investment advice or take into account the individual financial

circumstances or investment objectives of the clients who receive it. Barclays is not a fiduciary to any recipient of this publication. The securities and

other investments discussed herein may not be suitable for all investors and may not be available for purchase in all jurisdictions. The United States

imposed sanctions on certain Chinese companies (https://ofac.treasury.gov/sanctions-programs-and-country-information/chinese-military-

companies-sanctions), which may restrict U.S. persons from purchasing securities issued by those companies. Investors must independently evaluate

the merits and risks of the investments discussed herein, including any sanctions restrictions that may apply, consult any independent advisors they

believe necessary, and exercise independent judgment with regard to any investment decision. The value of and income from any investment may

fluctuate from day to day as a result of changes in relevant economic markets (including changes in market liquidity). The information herein is not

intended to predict actual results, which may differ substantially from those reflected. Past performance is not necessarily indicative of future results.

The information provided does not constitute a financial benchmark and should not be used as a submission or contribution of input data for the

purposes of determining a financial benchmark.

This publication is not investment company sales literature as defined by Section 270.24(b) of the US Investment Company Act of 1940, nor is it

intended to constitute an offer, promotion or recommendation of, and should not be viewed as marketing (including, without limitation, for the